Everest Organics is currently trading at its upper limit of Rs. 281.60, up by 25.60 points or 10.00% from its previous closing of Rs. 256.00 on the BSE.
The scrip opened at Rs. 264.00 and has touched a high and low of Rs. 281.60 and Rs. 250.00 respectively. So far 45310 shares were traded on the counter.
The BSE group 'X' stock of face value Rs. 10 has touched a 52 week high of Rs. 281.60 on 10-Aug-2020 and a 52 week low of Rs. 80.00 on 20-Apr-2020.
Last one week high and low of the scrip stood at Rs. 281.60 and Rs. 198.15 respectively. The current market cap of the company is Rs. 225.28 crore.
The promoters holding in the company stood at 73.79%, while Institutions and Non-Institutions held 0.03% and 26.19% respectively.
Everest Organics has developed Remdesivir API. Remdesivir API has been successfully developed in the R & D facility of the company.
Everest Organics is a fast growing API and Bulk drug manufacturing company with world class facility and it is committed to manufacturing excellent quality products and customer service.
